Question 1

What's the Syncom Formulations (India) Ltd share price today?

Accepted Answer

Syncom Formulations (India) Ltd share price was Rs 19.25 at close on 30th Oct 2026. Syncom Formulations (India) Ltd share price was down by 5.78% from the previous closing price of Rs 20.43. Syncom Formulations (India) Ltd share price trend:

Last 1 Month: Syncom Formulations (India) Ltd share price moved down by 23.71% on BSE
Last 3 Months: Syncom Formulations (India) Ltd share price moved up by 47.66% on BSE
Last 12 Months: Syncom Formulations (India) Ltd share price moved up by 15.35% on BSE
Last 3 Years: Syncom Formulations (India) Ltd price moved up by 127.15% on BSE

Question 2

How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?

Accepted Answer

The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 21.14
Price to book value ratio is 4.36
Dividend yield of 0.52
The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.91

Question 3

What is the market cap of Syncom Formulations (India) Ltd?

Accepted Answer

Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,810 crore.

Question 4

What is Syncom Formulations (India) Ltd's 52-week high/low share price?

Accepted Answer

The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 27.53 and 52-week low share price is Rs 10.21.

Question 5

Is the Syncom Formulations (India) Ltd profitable?

Accepted Answer

On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 24.85 crore on a total income of Rs 133.36 crore for the quarter ended 2026. For the year ended Jun 2026, Syncom Formulations (India) Ltd had posted a profit of Rs 24.85 crore on a total income of Rs 133.36 crore.

Question 6

Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?

Accepted Answer

Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are  Indoco Remedies, Panacea Biotec, Windlas Biotech, Syncom Formul., Titan Biotech, Venus Remedies, NGL Fine Chem.

Question 7

Who owns how much in Syncom Formulations (India) Ltd?

Accepted Answer

Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:

Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Sep 2026 from 50.57 per cent as of Dec 2025.
Indian Public holding in Syncom Formulations (India) Ltd has gone down to 42.37 per cent as of Sep 2026 from 45.04 per cent as of Dec 2025.
Non Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 4.83 per cent as of Sep 2026 from 4.13 per cent as of Dec 2025.
Foreign Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 2.22 per cent as of Sep 2026 from 0.26 per cent as of Dec 2025.
Other Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 0.01 per cent as of Sep 2026 from 0.00 per cent as of Dec 2025.
Financial Institutions holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Sep 2026 from 0.00 per cent as of Dec 2025.
Insurance Companies holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Sep 2026 from 0.00 per cent as of Dec 2025.
Mutual Funds Uti holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Sep 2026 from 0.00 per cent as of Dec 2025.
Custodians holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Sep 2026 from 0.00 per cent as of Dec 2025.

Market Cap (₹ Cr)	1,810
Traded Value (₹ Cr)	1.04
Volume (Shares)	5,39,300
Face Value (₹)	1

52-Week High (₹)	27.53
52-Week High Date	30-Sep-2026
52-Week Low (₹)	10.21
52-Week Low Date	30-Mar-2026

All Time High (₹)	27.94
All Time High Date	10-Sep-2024
All Time Low (₹)	0.14
All Time Low Date	15-Jan-1998

Syncom Formulations (India) Share Price

Syncom Formulations (India) Ltd